Standard Life Private Equity Trust — Focused on a broader opportunity set

Patria Private Equity Trust (LSE: PPET)

Last close As at 21/11/2024

GBP5.39

4.00 (0.75%)

Market capitalisation

GBP821m

More on this equity

Research: Investment Companies

Standard Life Private Equity Trust — Focused on a broader opportunity set

Standard Life Private Equity Trust (SLPE) aims to achieve long-term total returns via investing in a focused, primarily European portfolio of leading private equity buyout funds. The investment policy was revised in January 2017, removing size and geographic restrictions, to enlarge the investment opportunity set without diluting the trust’s strategy and focus. New fee arrangements have been agreed, with a single annual management fee of 0.95% of NAV and no incentive fee. The board has also stated its intention to raise the FY17 dividend to 12.0p, equating to a 3.8% yield, and grow it at least in line with inflation. Returns have been notably strong over one year.

Analyst avatar placeholder

Written by

Investment Companies

Standard Life Private Equity Trust

Focused on a broader opportunity set

Investment trusts

2 May 2017

Price

316.3p

Market cap

£486m

AUM

£541m

NAV*

355.9p

Discount to NAV

11.1%

*Estimated NAV as at 31 March 2017.

FY17 prospective yield

3.8%

Ordinary shares in issue

153.7m

Code

SLPE

Primary exchange

LSE

AIC sector

Private Equity

Benchmark

None

Share price/discount performance

Three-year performance vs index

52-week high/low

325.5p

215.0p

356.0p

303.0p

**Including income.

Gearing

Gross*

0.0%

Net cash*

17.9%

*As at 31 March 2017.

Analysts

Gavin Wood

+44 (0)20 3681 2503

Sarah Godfrey

+44 (0)20 3681 2519

Standard Life Private Equity Trust is a research client of Edison Investment Research Limited

Standard Life Private Equity Trust (SLPE) aims to achieve long-term total returns via investing in a focused, primarily European portfolio of leading private equity buyout funds. The investment policy was revised in January 2017, removing size and geographic restrictions, to enlarge the investment opportunity set without diluting the trust’s strategy and focus. New fee arrangements have been agreed, with a single annual management fee of 0.95% of NAV and no incentive fee. The board has also stated its intention to raise the FY17 dividend to 12.0p, equating to a 3.8% yield, and grow it at least in line with inflation. Returns have been notably strong over one year.

12 months ending

Share price
(%)

NAV

(%)

LPX 50
(%)

LPX 50 NAV (%)

MSCI World (%)

FTSE All-Share (%)

31/12/12

32.0

0.9

25.3

10.1

11.3

12.3

31/12/13

23.2

11.5

38.2

13.6

24.9

20.8

31/12/14

10.0

8.8

4.2

8.8

12.2

1.2

31/12/15

1.1

8.0

5.9

4.9

5.4

1.0

31/12/16

43.0

29.9

29.8

29.3

29.1

16.8

Source: Thomson Datastream, Bloomberg. Note: Twelve-month discrete £-adjusted total return performance up to last published quarter-end NAV.

Investment strategy: Europe-focused fund selection

SLPE invests via primary commitments and secondary transactions in what the manager views as the leading European private equity buyout funds. The aim is for the portfolio to comprise around 35 to 40 active private equity fund investments, broadly diversified by country, sector and maturity. The manager employs a bottom-up approach to private equity fund selection, with a top-down overlay designed to direct the investment team towards attractive geographies, sectors and strategies. Exposure is managed through the primary and secondary funds markets.

Market outlook: Attractive opportunities exist

Private equity funds’ uninvested capital is at peak levels, reaching US$869bn globally in H116, but SLPE’s manager notes this remains lower than the expected level of investment over a typical five-year private equity fund investment period, and does not anticipate higher purchase prices leading to significantly depressed returns. While European private equity deal volumes have been volatile, the manager reports fairly steady activity in the mid-market segment on which SLPE is focused. Should an economic downturn or potential market dislocation occur, this could provide an attractive opportunity for tactical investment. In the current pricing environment, the manager sees potential for smaller, region-specific funds – which face less competition for deals – to provide attractive opportunities.

Valuation: Narrowed discount, increased yield

Having followed a broadly widening trend over the previous two years, SLPE’s share price discount to NAV has narrowed from 36.5% in March 2016 to its current level of 11.1%, which stands as one of the narrowest in the peer group. The board intends to increase the FY17 dividend to 12.0p, equating to a prospective yield of 3.8%, leading the dividend-paying funds in SLPE’s peer group.

Exhibit 1: Trust at a glance

Investment objective and fund background

Recent developments

SLPE’s objective is to achieve long-term total returns through investing in a diversified portfolio of leading private equity buyout funds, a majority of which will have a European focus, with exposure managed through the primary and secondary funds markets. The investment policy was revised in January 2017 to remove size and geographic restrictions, with no change to the portfolio composition. The board has concluded that there is currently no available benchmark that is an appropriate measure of SLPE’s investment performance.

18 April 2017: March 2017 estimated NAV per share 355.9p.

24 March 2017: Qtrly update to 31 Dec 2016: NAV per share +4.3% to 361.2p.

1 February 2017: Change of ticker from SEP to SLPE.

31 January 2017: Change of name to Standard Life Private Equity Trust.

24 January 2017: AGM approval to change investment policy.

5 December 2016: Final results for year-ended 30 Sept 2016 – NAV total return +24.8%; 3.6p final dividend recommended. Board proposal to change the investment policy, dividend policy and fee arrangements.

Forthcoming

Capital structure

Fund details

AGM

January 2018

Ongoing charges

0.99% (FY16 direct fees)

Group

SL Capital Partners LLP

Interim results

8 June 2017

Net cash

17.9%

Manager

Team managed

Year end

30 September

Annual mgmt fee

0.95% of net assets

Address

1 George Street,

Edinburgh EH2 2LL

Dividend paid

July, January

Performance fee

None

Launch date

May 2001

Trust life

Indefinite

Phone

0131 245 0055

Continuation vote

N/A

Loan facilities

£80m revolving credit facility

Website

www.slcapital.com/slpet

Dividend policy and history (financial years)

Share buyback policy and history (financial years)

The board has stated its intention to increase the total dividend to 12.0p for FY17 and maintain the real value of the annual dividend in future years. An interim dividend was introduced in FY15.

The board views buybacks as part of its strategy in relation to capital efficiency. SLPE has authority to repurchase 14.99% and allot 5.0% of issued share capital. No shares have been repurchased since August 2016.

Shareholder base (as at 27 March 2017)

Portfolio exposure by fund type (as at 30 September 2016)

Top 10 underlying holdings (as at 30 September 2016)

Year of

investment

% of net assets

Company

Business

Fund

30 Sept 2016

30 Sept 2015*

Action

Non-food discount retailer

3i Eurofund V

2011

6.1

3.4

Scandlines

Northern European ferry operator

3i Eurofund V

2007

1.7

1.2

Lindorff

Debt collection & accounting services

Nordic Capital VIII

2014

1.3

0.9

Quironsalud

Spanish private healthcare provider

CVC European Equity Partners V

2011

1.2

0.6

Schenck Process

Industrial weighing systems

Industri Kapital 2007

2007

1.2

1.2

Parques Reunidos

Amusement parks

Candover 2005 Fund

2007

1.0

1.7

Not disclosed

Recovery audit services

Advent Global Private Equity VI

2012

1.0

0.8

AWAS/Pegasus

Aircraft lessor

Terra Firma Capital Partners III

2007

0.9

1.2

Not disclosed

Pets services and solutions retailer

BC European Capital IX

2015

0.9

N/A

Cérélia

Ready-to-use dough manufacturer

IK VII

2015

0.9

0.7

Top 10 at each date

16.2

15.0

Source: SLPE, Edison Investment Research, Bloomberg, Thomson Reuters, Morningstar. Note: *N/A where not in September 2015 top 30.

Changes to investment policy, fees and dividends

In December 2016, following a strategic review, the board proposed changes to the trust’s investment policy, dividend policy and fee arrangements. To reflect the investment policy changes, which removed the size and geographic restrictions on private equity investments, the board recommended a change in the trust’s name to Standard Life Private Equity Trust (from Standard Life European Private Equity Trust). The revisions to the investment policy and name change were approved by shareholders at the January 2017 AGM.

Investment policy revisions

The key aim of the investment policy changes was to increase the private equity opportunity set without diluting the trust’s strategy and focus. No portfolio changes were made as a result of the policy revisions and shareholders should not expect a radical shift in the composition of the trust’s portfolio, which will remain concentrated with a European focus.

The manager was previously constrained to investing in private equity funds targeting transactions with €100m to €2.0bn enterprise values and principally investing in Europe. The size constraints had been widened in 2015, while US exposure had been steadily rising, reaching 21.0% in FY16.

The cash management policy was broadened to include opportunistic utilisation of listed direct private equity investments (in suitably liquid companies), in order to maximise returns on cash held pending investment. SLPE had previously invested this cash in equity index tracker funds.

New fee arrangements

The board has agreed new fee arrangements with the manager for FY17, with a single annual management fee of 0.95% of net asset value replacing the previous 0.8% management fee and success-based performance fee, which had a set five-year life expiring at the end of FY16.

Dividend policy changes

The board has stated that it will raise the FY17 total dividend to 12.0p and has committed to maintaining the real value of the dividend through growing it at least in line with inflation, in the absence of unforeseen circumstances. The board modified its approach to dividends in FY14, focusing on maintaining the real value of the dividend, and introduced an interim dividend in FY15.

Fund profile: Europe-focused diversified fund of funds

Launched in May 2001, SLPE is an LSE-listed investment trust aiming to achieve long-term total returns through investing in a diversified portfolio of private equity buyout funds, a majority of which will have a European focus. The investment strategy involves rigorous screening and detailed due diligence to identify and evaluate prospective private equity fund investments. Historically, private equity funds have delivered a wide dispersion of returns and the manager considers that access to leading private equity managers and appropriate fund selection are vital to optimise investment performance. The objective is for SLPE’s portfolio to comprise around 35 to 40 active private equity fund investments at any one time, with portfolio diversification being controlled via concentration limits, which are applied at an individual fund (12.5% of NAV) and manager (20.0% of NAV) level.

SLPE’s investment manager, SL Capital Partners, ranks among the largest investors in private equity funds and co-investments in Europe, having raised c £9.0bn of private equity funds on behalf of over 200 clients worldwide. Led by Roger Pim, Graeme Gunn and Peter McKellar, the investment team comprises 32 professionals and the senior executives have worked together for an average of nine years. The manager believes that its scale and the team’s experience enable it to identify and invest in Europe’s premier private equity funds, knowledge of and access to which may be limited in the wider market.

The fund manager: SL Capital Partners

The manager’s view: Retaining existing focus, adding flexibility

SL Capital senior executive Graeme Gunn observes that, while private equity funds’ uninvested capital is at record levels globally, reaching US$869bn in H116, this remains less than the expected capital that would be invested over the five-year investment period that is common for private equity funds. Consequently, he sees limited evidence that returns will be significantly depressed by private equity managers paying higher prices for deals or investing in lower quality companies. Although he concedes that returns for 2015 and 2016 vintage investments may not match those from the three previous years, his view is that the generally more conservative debt levels applied to deals keeps risk levels manageable and returns will be acceptable. While he would like to see more deal volume across the private equity market in general, Gunn reports that volumes have been fairly steady in the mid-market segment that remains SLPE’s core focus. He views private equity as a stock-picking investment strategy where returns tend to have a low correlation to the broader macroeconomic and political developments that can lead to elevated volatility in listed markets.

On a five-year view, Gunn notes that a significant change – potentially a dislocation – in the global economy is still expected, and that SLPE continues to be positioned with this in mind. However, he highlights that, while focused on maintaining a strong capital position to take advantage of tactical investment opportunities, SLPE has continued actively making new primary investment commitments, including €34.0m to IK VIII in October 2016 and £22.0m to HgCapital 8 in February 2017. Gunn reflects that SLPE’s £312m outstanding commitments at end-March 2017, less £55m believed unlikely to be drawn, represents c 50% of NAV, which is considered a comfortable level. He also notes that SLPE’s £97.7m liquid resources and £80.0m undrawn credit facility bring unfunded commitments to less than 25% of NAV. Drawdowns continue to lag distributions and he highlights the strength of distributions in February and March 2017, with SLPE receiving £39.8m from 10 divestments across nine funds, at exit multiples ranging from 1.1x to 8.2x cost and uplifts to portfolio valuation prior to realisation of 0% to 92% (average 30%).

Gunn has no concerns over the size of the trust’s underlying holding in Action, which represents an unusually large c 6% of SLPE’s NAV. He observes that this reflects the successful nature of the investment, currently performing strongly, and highlights how, given the trust’s conviction strategy, individual companies can contribute materially to SLPE’s performance. Action is held via 3i Eurofund V and Gunn notes that the fund’s manager could look to float the company in due course.

Gunn confirms that there is no intention to make major changes to SLPE’s portfolio, with the most significant aspect of the investment policy changes seen to be the additional flexibility provided over secondary fund investments. He indicates that SLPE is more likely to add US exposure, noting that SL Capital has a Boston-based team managing US investments. He reiterates the intention to evolve SLPE’s portfolio to a primary to secondary investments ratio of c 70:30 compared with c 80:20 currently. SLPE’s largest recent secondary investment was a €20.0m original commitment to Nordic Capital VII, purchased in January 2017 for €22.1m at a 2.0% premium to the latest reported valuation. US$3.1m and US$1.6m original commitments to Towerbrook Investors III and IV were purchased in March 2017 for US$1.1m, a 15.9% discount to the latest reported valuation.

Following the removal of the deal size restrictions, Gunn indicates that SLPE is more likely to invest in smaller, region-specific funds, which can provide access to niche markets and often face less competition for deals, rather than adding exposure to larger transactions.

SLPE is reviewing how it will invest in listed direct private equity investment companies as part of its cash management strategy. Gunn sees a limited number of suitable companies and suggests that a basket of around five could be selected, following appropriate due diligence. He notes that these listed holdings will be the first call for drawdowns into portfolio funds, within envisaged hold periods.

Asset allocation

Investment strategy and process

Following the changes to the investment policy that took effect in January 2017, there are no restrictions on the enterprise value range of investments made by the funds in which SLPE invests (previously €100m and €2.0bn), or any constraints on the level of portfolio investments outside Europe (previously 20% of gross assets at the time of purchase). However, SLPE’s investment policy retains a reference to Europe, as a majority of the portfolio will have a European focus.

SLPE’s principal focus is to invest in what the manager views as the leading private equity buyout funds. The aim is for the portfolio to comprise around 35 to 40 active fund investments. SLPE’s policy is to maintain a broadly diversified portfolio by country, industry sector, maturity and number of underlying investments. The investment team’s extensive fund and direct deal experience gives the manager a strong insight into the strategies, processes and disciplines of the funds considered for investment, which is considered to lead to better qualitative judgements being made.

SLPE has increased its focus on the private equity secondary market, acquiring or selling selected fund interests to fine-tune portfolio exposures as well as maintain capital efficiency. Secondary investments typically generate lower absolute returns, but shorter holding periods can lead to higher internal rates of return (IRRs) being achieved. The manager expects c 1.4x exit multiples with IRRs of 20% to 25% for secondary investments, compared with c 1.8x exit multiples and IRRs of 17% to 18% for primary investments. Fully invested secondary interests also have a lower risk profile than primary commitments, as underlying holdings can be evaluated prior to purchase.

SL Capital Partners follows a systematic, disciplined approach to investment selection, monitoring and realisation. The investment process broadly breaks down into three stages, comprising the preparation of a deal qualification memorandum (DQM), preliminary investment recommendation (PIR) and final investment recommendation (FIR). Each year, DQMs are prepared on around 100 to 150 of the c 800 institutional-grade private equity funds in Europe that are monitored, with about 25 funds reaching the PIR stage. SL Capital typically commits to 10-15 primary fund investments and completes at least 15 secondary transactions each year, with SLPE making around four primary and five secondary investments a year.

To maximise the level of invested assets, the manager pursues an over-commitment strategy, making fund commitments that exceed SLPE’s available capital, based on an assessment of scheduled and projected portfolio cash flows. SLPE’s non-sterling currency exposure is primarily to the euro and US dollar. This exposure is not hedged due to the irregularity in size and timing of individual cash flows, but cash balances and bank debt are held broadly in proportion to the currency of the trust’s outstanding fund commitments.

Current portfolio positioning

At 30 September 2016, SLPE’s portfolio comprised 49 private equity fund interests with 478 underlying investments, representing holdings in 452 separate companies. Excluding four secondary fund investments made in 2001 and 2005/06, there are between 300 and 350 ‘core’ underlying companies. Underlining its focused approach, SLPE’s top 10 fund holdings at 30 September 2016 represented 45.9% of NAV, equal to 56.4% of the invested portfolio, with each fund holding 16 investments on average. The top 10 underlying company holdings accounted for 16.2% of NAV (see Exhibit 1), with seven companies each representing more than 1.0% (including one above 5%), a level at which they can make a material contribution to portfolio returns, thus differentiating SLPE’s exposure from the broader private equity market.

Exhibit 2: Portfolio diversification by geography and sector at 30 September 2016

Geographic exposure by portfolio value

Sector exposure by portfolio value

Source: SLPE, Edison Investment Research

Performance: Notably strong one-year returns

As shown in Exhibit 4, SLPE’s NAV total return has outperformed global private equity (PE) peers, represented by the LPX 50 index, over one, three and 10 years to end-December 2016, while underperforming over five years. Compared with European PE peers, represented by the LPX Europe index, SLPE’s NAV total return has outperformed over one, three, five and 10 years. The strengthening of the US dollar against the euro over three, five and 10 years (+30.1%, +22.6% and +28.7%) is likely to account for a significant element of the stronger NAV performance of the LPX 50 versus the LPX Europe over these periods. Exhibit 3 illustrates the strength of SLPE’s and the LPX 50 index’s NAV total return performance over one year, with the significant narrowing of SLPE’s discount reflected in its share price total return outperformance over this period. The 14.4% and 16.2% declines of sterling against the euro and US dollar over one year, largely driven by the UK’s vote to leave the EU in June 2016, have significantly added to performance in sterling terms.

Exhibit 3: Investment trust performance to 31 December 2016 (last published quarter-end NAV)

Price, NAV and index total return performance, one-year rebased

Price, NAV and index total return performance (%)

Source: Thomson Datastream, Edison Investment Research. Note: Three-, five- and 10-year performance figures annualised.

Exhibit 4: Share price and NAV total return performance, relative to indices (%)

 

Three months

Six months

One year

Three years

Five years

10 years

Price relative to LPX 50

4.1

10.3

10.2

11.1

4.4

2.5

Price relative to LPX Europe

5.3

9.6

12.0

3.6

1.0

1.6

Price relative to MSCI World

4.6

15.6

10.8

4.2

22.0

(31.4)

Price relative to FTSE All-Share

7.8

18.8

22.5

33.3

59.9

(2.4)

NAV relative to LPX 50 NAV

(1.7)

(0.7)

0.4

3.4

(7.0)

5.9

NAV relative to LPX Europe NAV

(0.8)

(0.9)

4.2

10.9

3.2

16.0

Source: Thomson Datastream, Edison Investment Research. Note: Data to end-December 2016. Geometric calculation.

Discount: Narrowing 12-month trend

As illustrated in Exhibit 5, over the last three years, SLPE’s share price discount to NAV has moved in a relatively wide range between 10% in June 2014 and 36% in March 2016. Having followed a broadly widening trend for the two years to March 2016, the discount has narrowed over the last year and currently stands at 11.1%, which compares to its three-year average of 20.7%.

Exhibit 5: Share price discount to NAV over three years (%)

Source: Thomson Datastream, Edison Investment Research

Capital structure and fees

SLPE has 153.7m ordinary shares in issue, having repurchased 2.0m shares (1.3% of outstanding capital) in the year to 30 September 2016. The board views share repurchases in relation to capital efficiency, alongside new fund commitments, secondary fund purchases and dividend payments. SLPE has an £80m credit facility running to December 2020, which was undrawn at 28 February 2017, with £89m held in cash and money market funds, equating to a 16.3% net cash position.

From FY17, SLPE will pay SL Capital a single annual management fee of 0.95% of NAV. SLPE previously paid a 0.8% pa management fee, with a 10% incentive fee on returns above 8% pa over the five years to end-FY16. Strong NAV growth triggered a £6.4m (1.2% of NAV) incentive fee payment. For FY16, excluding indirect fund fees and incentive fees, ongoing charges were 0.99%.

Dividend policy and record

The board believes that providing a strong, stable dividend is attractive to shareholders and, in December 2016, took the decision to increase the annual dividend to 12.0p per share for the year ending 30 September 2017, more than double the total dividend for FY16 and equating to a prospective yield of 3.9%. In addition, the board is committed to maintaining the real value of the dividend from this level, in the absence of unforeseen circumstances. FY16 interim and final dividends were both increased by 2.9%, bringing the total for the year to 5.4p. SLPE’s revenue reserves at 30 September 2016 stood at 5.7p per share after payment of the 3.6p final dividend.

Peer group comparison

Exhibit 6 shows a comparison of SLPE with a selected peer group of private equity funds of funds. SLPE’s NAV total return to 31 December 2016 (its last reported quarterly NAV date) is ahead of the peer group average over one year but below the average over three, five and 10 years. SLPE’s share price discount to NAV stands as one of the narrowest in the peer group. SLPE’s 0.99% FY16 ongoing charge (reflecting direct fees and excluding incentive fees) is the lowest in the peer group and is expected to remain competitive at c 1.15% following the replacement of the 0.8% pa management fee and incentive fee arrangement with a single 0.95% annual management fee from FY17, particularly as the majority of peers levy a performance fee. SLPE has not drawn against its £80m credit facility, leaving it ungeared, similar to the majority of peers. SLPE’s 3.8% yield, which reflects the proposed 12.0p FY17 dividend, leads the dividend-paying funds in the peer group.

Exhibit 6: Selected private equity fund of funds peer group as at 28 April 2017*

% unless stated

Region

Mkt cap £m

NAV TR 1 Year

NAV TR 3 Year

NAV TR 5 Year

NAV TR 10 Year

Discount (ex-par)

Ongoing charge

Perf. fee

Net gearing

Dividend yield (%)

Standard Life Private Equity

Europe

486.2

29.9

52.5

71.5

108.1

(9.8)

0.99

No

100

3.8

Aberdeen Private Equity

Global

130.1

19.2

56.0

64.9

(16.5)

1.87

Yes

100

3.4

F&C Private Equity Trust

Global

259.6

23.3

46.8

72.7

141.0

0.6

1.27

Yes

108

3.2

HarbourVest Global Private Equity

Global

994.3

28.4

76.9

102.7

(12.7)

2.16

No

100

0.0

ICG Enterprise Trust

Europe

513.7

19.5

28.8

57.5

108.4

(13.5)

1.41

No

100

2.7

JPEL Private Equity

Global

321.3

42.9

80.7

49.5

64.9

(14.2)

1.94

Yes

108

0.0

NB Private Equity Partners

Global

499.3

34.8

84.7

104.8

(15.7)

2.27

Yes

100

3.8

Pantheon International

Global

1,105.6

26.1

60.3

84.3

152.0

(17.0)

1.39

Yes

100

0.0

Average

538.8

28.0

60.8

76.0

114.9

(12.3)

1.66

102

2.1

Trust rank in sector

5

3

6

5

4

2

8

3

1

Source: Morningstar, Edison Investment Research. Note: *Performance data to 31 December 2016. TR = total return. All returns expressed in sterling terms.

The board

SLPE’s board comprises five independent non-executive directors. Edmond Warner (appointed director November 2008, chairman January 2013) is chairman of BlackRock Commodities Income Investment Trust and Grant Thornton UK, and a director of Clarkson. Senior independent director Christina McComb (appointed January 2013) spent 14 years with 3i Group and is chairman of OneFamily Mutual Assurance, senior independent director of the British Business Bank, and a director of Baronsmead Venture Trust and Nexeon. David Warnock (appointed January 2009), a co-founding partner at Aberforth Partners for 19 years until 2008, is chairman of Troy Income & Growth Trust and a director of Seneca Investment Managers. Alastair Barbour (appointed April 2011) is a director of RSA Insurance Group, Phoenix Group Holdings, Liontrust Asset Management and CATCo Reinsurance Opportunities Fund. Alan Devine (appointed May 2014) has 40 years' experience in both commercial and investment banking and recently retired from Royal Bank of Scotland Group, where he was CEO of RBS Shipping Group and a director of Cairn Capital.

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2017 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Standard Life Private Equity Trust and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable; however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2017. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2017 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Standard Life Private Equity Trust and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable; however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2017. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Patria Private Equity Trust

View All

Latest from the Investment Companies sector

View All Investment Companies content

Cellular Biomedicine Group — A transpacific cell therapy company

Cellular Biomedicine Group (CBMG) has seven preclinical CAR-T programs and two Phase I clinical trials using its CD19 CAR-T therapy in China, making it the only US-traded CAR-T company in this market. It has rights to the Dendristim lung cancer vaccine. In addition, it is adapting its osteoarthritis (OA) treatment ReJoin as an allogeneic product, AlloJoin, which will be developed in the US after an IND in 2017 or 2018.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free